NCT02500797 2023-10-17Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 2 Completed164 enrolled 22 charts